XLON
SPI
Market cap1.31bUSD
Oct 09, Last price
247.00GBP
1D
0.20%
1Q
14.09%
Jan 2017
-26.86%
IPO
17.62%
Name
Spire Healthcare Group PLC
Chart & performance
P/E
60.33
P/S
0.63
EPS
0.04
Div yield, %
0.93%
Shrs. gr., 5y
0.22%
Rev. gr., 5y
11.42%
Revenues
1.58b
+4.54%
Net income
16m
-35.43%
CFO
219m
-6.96%
Dividend
May 21, 20261.5 GBP/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Established in 2016 and headquartered in Perth, Australia, Sierra Rutile Holdings Limited is primarily involved in multi-mine mineral sands operations. Its extensive assets include various mineral sand deposits located across southern Sierra Leone, specifically within the Moyamba and Bonthe districts. Among these holdings is the significant Sembehun project, also situated in the Moyamba district. A key historical detail is its operational independence from Iluka Resources Limited, a status achieved on August 4, 2022.
Related entities
Subsidiaries
SPIRE HEALTHCARE FINANCE LIMITED
Key people
Non-Executive Chairman of the Board · since 2017
Deputy Chairman of the Board, Senior Independent Director · since 2019
John Forrest
Chief Operating Officer · since 2018
Daniel Toner
General Counsel, Group Company Secretary · since 2015
Justin Ash
Chief Executive Officer, Executive Director · since 2017
Chief Financial Officer, Executive Director · since 2018
Andrew White
Executive Director · since 2016
Antony Mannion
Director, Strategy and Investor Relations · since 2019
Peter Corfield
Chief Commercial Officer · since 2018
Jean-Jacques de Gorter
Chief Medical Officer · since 2018
Alison Dickinson
Group Clinical Director · since 2018
Non-Executive Director · since 2018
Adele Anderson
Independent Non-Executive Director · since 2016
Independent Non-Executive Director · since 2014
Janet Husband
Independent Non-Executive Director · since 2014
IPO date
Jul 18, 2014
Employees
2,000
Domiciled in
GB
Incorporated in
GB
Headquarters & legal address
3 DORSET RISE
LONDON, LND EC4Y 8EN
GB
LONDON, LND EC4Y 8EN
GB
Previous name
SPIRE HEALTHCARE GROUP LIMITED
Valuation
Title GBP in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||